Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Genmab A/S (GMAB) Stock Analysis: Uncovering a 31% Potential Upside in the Biotech Sector 18 August 2025
Regencell Bioscience Holdings (RGC): A Unique Play in Healthcare with Intriguing Technicals 18 August 2025
Elanco Animal Health (ELAN): Stock Analysis Shows Modest Upside Amidst Strong Product Portfolio 18 August 2025
Penumbra, Inc. (PEN) Stock Analysis: 22.87% Potential Upside in Medical Device Innovation 18 August 2025
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with a 44% Upside Potential 18 August 2025
Alkermes plc (ALKS) Investor Outlook: Strong Buy Ratings and 42.86% Upside Potential Highlight Growth Prospects 18 August 2025
Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Robust Revenue Growth Amidst High Potential Upside 18 August 2025
Haleon plc (HLN) Stock Analysis: Exploring a 20% Upside Potential in a Stable Healthcare Giant 18 August 2025
Ionis Pharmaceuticals (IONS) Stock Analysis: Unlocking a 33% Potential Upside in RNA-Targeted Medicines 18 August 2025
Stryker Corporation (SYK) Stock Analysis: Unlocking a 13% Upside Potential with Strong Buy Ratings 18 August 2025
ICON plc (ICLR) Stock Analysis: A 24% Upside Potential Beckons in the Healthcare Sector 18 August 2025
Viatris Inc. (VTRS) Stock Analysis: Evaluating a Potential 7.72% Upside in the Healthcare Sector 18 August 2025
Blueprint Medicines Corporation (BPMC): Investor Outlook Amid Strong Revenue Growth and Technical Opportunities 18 August 2025
Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 22.77% Potential Upside Amid Strong Revenue Growth 18 August 2025
Nuvalent, Inc. (NUVL) Stock Analysis: Biotech Innovator Offers a Potential 52.91% Upside 18 August 2025
Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 19.28% Potential Upside for Investors 18 August 2025
Hercules Plc Training 2,000 Workers to Help Solve the UK Infrastructure Skills Crisis (Video) 17 November 2025
Firering Strategic Minerals $1M Ricca Settlement Injects Momentum into Lithium Strategy (Video) 14 November 2025
ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video) 11 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
